Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 56
Filtrar
1.
Sheng Li Xue Bao ; 75(6): 779-787, 2023 Dec 25.
Artigo em Chinês | MEDLINE | ID: mdl-38151343

RESUMO

Atrial fibrillation (AF) is a cardiovascular epidemic that occurs primarily in the elderly with primary cardiovascular diseases, leading to severe consequences such as stroke and heart failure. The heart is an energy-consuming organ, which requires a high degree of metabolic flexibility to ensure a quick switch of metabolic substrates to meet its energy needs in response to physiological and pathological stimulation. Metabolism is closely related to the occurrence of AF, and AF patients manifest metabolic inflexibility, such as insulin resistance and the metabolic shift from aerobic metabolism to anaerobic glycolysis. Moreover, our research group and the others have shown that metabolic inflexibility is a crucial pathologic mechanism for AF. Energy metabolism is closely linked to the aging process and aging-related diseases, and impaired metabolic flexibility is considered as an essential driver of aging. Therefore, this review focuses on the alteration of metabolic flexibility in the elderly and reveals that impaired metabolic flexibility may be an important driver for the high prevalence of AF in the elderly, hoping to provide intervention strategies for the prevention and treatment of AF in the elderly.


Assuntos
Fibrilação Atrial , Insuficiência Cardíaca , Acidente Vascular Cerebral , Humanos , Idoso , Fibrilação Atrial/epidemiologia , Anticoagulantes , Envelhecimento
2.
Pacing Clin Electrophysiol ; 44(11): 1817-1823, 2021 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-33973650

RESUMO

BACKGROUND: It remains uncertain whether low-level electrical stimulation (LL-ES) of the ventricular ganglionated plexi (GP) improves heart function. This study investigated the anti-arrhythmic and anti-heart failure effects of LL-ES of the aortic root ventricular GP (ARVGP). METHODS: Thirty dogs were divided randomly into control, drug, and LL-ES groups after performing rapid right ventricular pacing to establish a heart failure (HF) model. The inducing rate of arrhythmia; levels of bioactive factors influencing HF, including angiotensin II type I receptor (AT-1R), transforming growth factor-beta (TGF-ß), matrix metalloproteinase (MMP), and phosphorylated extracellular signal-regulated kinase (p-ERK1/2); left ventricular stroke volume (LVSV), and left ventricular ejection fraction (LVEF)were measured after treatment with placebo, drugs, and LL-ES. RESULTS: The inducing rate of atrial arrhythmia decreased from 60% in the control group to 50% in the drug group and 10% in the LL-ES group (p = .033 vs. drug group) after 1 week of treatment. The ventricular effective refractory period was prolonged from 139 ± 8 ms in the drug group to 166 ± 13 ms in the LL-ES group (p = .001). Compared to the drug group, the expressions of AT-1R, TGF-ß, and MMP proteins were down-regulated in the LL-ES group, whereas that of p-ERK1/2 was significantly increased (all p = .001). Moreover, in the LL-ES group, LVSV increased markedly from 13.16 ± 0.22 to 16.86 ± 0.27 mL, relative to that in the drug group (p = .001), and LVEF increased significantly from 38.48% ± 0.53% to 48.94% ± 0.57% during the same time frame (p = .001). CONCLUSION: Short-term LL-ES of ARVGP had both anti-arrhythmic and anti-inflammatory effects and contributed to the treatment of tachycardia-induced HF and its associated arrhythmia.


Assuntos
Arritmias Cardíacas/prevenção & controle , Estimulação Elétrica , Gânglios Autônomos/fisiologia , Átrios do Coração/fisiopatologia , Insuficiência Cardíaca/prevenção & controle , Ventrículos do Coração/inervação , Ventrículos do Coração/fisiopatologia , Animais , Arritmias Cardíacas/fisiopatologia , Biomarcadores/sangue , Modelos Animais de Doenças , Cães , Insuficiência Cardíaca/fisiopatologia , Volume Sistólico
3.
Zhongguo Zhong Yao Za Zhi ; 46(17): 4511-4521, 2021 Sep.
Artigo em Chinês | MEDLINE | ID: mdl-34581057

RESUMO

This study aims to explore the active components and molecular mechanism of Shenmai Injection in the treatment of atrial fibrillation(AF) based on the application of network pharmacology and molecular docking technology. The chemical components of single herbs of Shenmai Injection were collected from TCMSP and TCMID, with the standard chemical name and PubChem CID(referred to as CID) obtained from PubChem database. The active components were screened using SwissADME, and their targets were predicted using SwissTargetPrediction. Targets related to AF treatment were identified using GeneCards, OMIM, and other databases. Venn diagram was constructed using Venny 2.1 to obtain the intersection targets. The single herb-active component-potential target network was constructed using Cytoscape, and the clusterProfiler R function package was used to perform the gene ontology(GO) and Kyoto encyclopedia of genes and genomes(KEGG) pathway enrichment. The protein-protein interaction(PPI) network of intersection targets was generated based on the STRING database. The hub target protein was identified by visualization using Cytoscape, and then docked to its reverse-selected active components. The analysis showed that there were 65 active components with 681 corresponding targets in Shenmai Injection, 2 798 targets related to AF treatment, and 235 intersection targets involving 2 549 GO functions and 153 KEGG pathways. Finally, hub target proteins, including RAC-alpha serine/threonine-protein kinase(AKT1), phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha(PIK3 CA), and estrogen receptor 1(ESR1), were screened out by PPI network visualization. The molecular docking was performed for 39 active components screened out in reverse, among which 30 active components de-monstrated high affinity. Among them, homoisoflavanoids CID 10871974, CID 5319742, and CID 10361149 had stronger affinity docking with AKT1. This study preliminarily indicates that Shenmai Injection treats AF through multiple components, multiple targets, and multiple pathways. Homoisoflavonoids of Ophiopogon japonicus are its important active components, which target AKT1 to regulate metabolism, inflammation, and apoptosis in AF treatment.


Assuntos
Fibrilação Atrial , Medicamentos de Ervas Chinesas , Fibrilação Atrial/tratamento farmacológico , Combinação de Medicamentos , Humanos , Medicina Tradicional Chinesa , Simulação de Acoplamento Molecular
4.
Scand J Gastroenterol ; 52(1): 34-43, 2017 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-27610642

RESUMO

Gallstone disease is a common and frequently occurring disease in human, and it is the main disease among the digestive system diseases. The incidence of gallstone disease in western countries is about 5%-22%, and common bile duct stones (CBDS) accounts for 8%-20%. CBDS easily lead to biliary obstruction, secondary cholangitis, pancreatitis, and obstructive jaundice, even endanger life. Therefore, it needs timely treatment once diagnosed. The recurrence of choledocholithiasis after bile duct stones clearance involves complicated factors and cannot be completely elaborated by a single factor. The risk factors for recurrence of choledocholithiasis include bacteria, biliary structure, endoscopic and surgical treatment, and inflammation. The modalities for management of choledocholithiasis are endoscopic retrograde cholangiopancreatography (ERCP), laparoscopic or open common bile duct exploration, dissolving solutions, extracorporeal shockwave lithotripsy (ESWL), percutaneous radiological interventions, electrohydraulic lithotripsy (EHL) and laser lithotripsy. We compare the different benefits between surgery and ERCP. And finally, we make a summary of the current strategy for reducing the recurrence of CBDS and future perspectives for CBDS management.


Assuntos
Colangiopancreatografia Retrógrada Endoscópica , Colecistectomia Laparoscópica , Coledocolitíase/terapia , Cálculos Biliares/cirurgia , Litotripsia , Coledocolitíase/complicações , Humanos , Incidência , Icterícia/etiologia , Pancreatite/etiologia , Ensaios Clínicos Controlados Aleatórios como Assunto , Recidiva , Fatores de Risco
5.
Undersea Hyperb Med ; 43(3): 207-15, 2016.
Artigo em Inglês | MEDLINE | ID: mdl-27416688

RESUMO

The objective of this retrospective study was to analyze the relationship between sex and prognosis after carbon monoxide (CO) poisoning. Sixty-six couples diagnosed with CO poisoning were divided into two groups according to premenopausal or postmenopausal females. The prognosis was compared between husbands and wives. A multiple-factor analysis was conducted to determine the effects of sex and age on prognosis. The wives had higher Glasgow Outcome Scale (GOS) scores (P = 0.012) and cure and improvement rate (P = 0.013) than did their husbands within the same poisoning environment. In the premenopausal group, the wives had higher GOS scores (P = 0.023) and cure and improvement rate (P = 0.035) than did their husbands, which was not present in the postmenopausal group. Females had milder classifications in 24 hours (odds ratio [OR] = 2.968; P = 0.010). Females (OR = 0.485; P = 0.034) or patients younger than 40 years old (OR = 5.760; P < 0.001) had higher GOS scores. As the patients diagnosed with mild or moderate poisoning were excluded, age was still related to the GOS scores (OR = 5.714; P = 0.001), but not sex. Females have an advantage over their male spouses in terms of the severity of poisoning and prognosis after CO poisoning, particularly in premenopausal couples. Sex is an important prognostic indicator in CO poisoning.


Assuntos
Intoxicação por Monóxido de Carbono , Escala de Resultado de Glasgow , Oxigenoterapia Hiperbárica , Índice de Gravidade de Doença , Fatores Sexuais , Cônjuges , Adulto , Fatores Etários , Idoso , Intoxicação por Monóxido de Carbono/classificação , Intoxicação por Monóxido de Carbono/complicações , Intoxicação por Monóxido de Carbono/diagnóstico , Intoxicação por Monóxido de Carbono/terapia , Feminino , Humanos , Modelos Logísticos , Masculino , Pessoa de Meia-Idade , Pós-Menopausa , Pré-Menopausa , Prognóstico , Estudos Retrospectivos , Resultado do Tratamento
6.
J Environ Biol ; 37(5 Spec No): 1153-1165, 2016 09.
Artigo em Inglês | MEDLINE | ID: mdl-29989748

RESUMO

The recovery of waste electrical and electronic equipment (WEEE) has become a major issue for solid waste management. Exploring new ways to dispose of WEEE has become mandatory in most of the countries in the world. Reverse logistics which is the backward flows of used product from consumers to producers is an important stage dealing with the WEEE. The reverse logistics network design for WEEE plays an important role in the total cost of recovery system. With this study, taking into account the uncertainty of reverse logistics network operation for WEEE, a robust mixed integer linear programming model for WEEE reverse logistics network was established for handling problem, which was affected by the uncertainty of recovery based on the risk preference coefficient and penalty coefficient deviated from the constraints, that could allow decision-makers to adjust the robust level of the operation system and risk preferences. The calculation and simulation of the model is used for lingo 11.0. The result showed that the robust mixed integer linear programming model was better than the classic model, which had a lower operational risk and could give consideration to the cycles of different circumstances that is effective in inhibiting the uncertainty ofreverse logistics system for WEEE.


Assuntos
Resíduo Eletrônico , Reciclagem , Eliminação de Resíduos/métodos , Modelos Teóricos , Reciclagem/economia , Reciclagem/métodos , Eliminação de Resíduos/economia
7.
BMC Cell Biol ; 16: 22, 2015 Sep 03.
Artigo em Inglês | MEDLINE | ID: mdl-26335746

RESUMO

BACKGROUND: Environmental factors are important for stem cell lineage specification, and increasing evidence indicates that the nanoscale geometry/topography of the extracellular matrix (ECM) directs stem cell fate. Recently, many three-dimensional (3D) biomimetic nanofibrous scaffolds resembling many characteristics of the native ECM have been used in stem cell-based myocardial tissue engineering. However, the biophysical role and underlying mechanism of 3D nanofibrous scaffolds in cardiomyocyte differentiation of induced pluripotent stem cells (iPSCs) remain unclear. RESULTS: Here, we fabricated a 3D poly-(ε-caprolactone) (PCL) nanofibrous scaffold using the electrospinning method and verified its nanotopography and porous structure by scanning electron microscopy. We seeded murine iPSCs (miPSCs) directly on the 3D PCL nanofibrous scaffold and initiated non-directed, spontaneous differentiation using the monolayer method. After the 3D PCL nanofibrous scaffold was gelatin coated, it was suitable for monolayer miPSC cultivation and cardiomyocyte differentiation. At day 15 of differentiation, miPSCs differentiated into functional cardiomyocytes on the 3D PCL nanofibrous scaffold as evidenced by positive immunostaining of cardiac-specific proteins including cardiac troponin T (cTnT) and myosin light chain 2a (MLC2a). In addition, flow cytometric analysis of cTnT-positive cells and cardiac-specific gene and protein expression of cTnT and sarcomeric alpha actinin (α-actinin) demonstrated that the cardiomyocyte differentiation of miPSCs was more efficient on the 3D PCL nanofibrous scaffold than on normal tissue culture plates (TCPs). Furthermore, early inhibition of Wnt/ß-catenin signaling by the selective antagonist Dickkopf-1 significantly reduced the activity of Wnt/ß-catenin signaling and decreased the cardiomyocyte differentiation of miPSCs cultured on the 3D PCL nanofibrous scaffold, while the early activation of Wnt/ß-catenin signaling by CHIR99021 further increased the cardiomyocyte differentiation of miPSCs. CONCLUSION: These results indicated that the electrospun 3D PCL nanofibrous scaffolds directly promoted the cardiomyocyte differentiation of miPSCs, which was mediated by the activation of the Wnt/ß-catenin signaling during the early period of differentiation. These findings highlighted the biophysical role of 3D nanofibrous scaffolds during the cardiomyocyte differentiation of miPSCs and revealed its underlying mechanism involving Wnt/ß-catenin signaling, which will be helpful in guiding future stem cell- and scaffold-based myocardium bioengineering.


Assuntos
Diferenciação Celular , Células-Tronco Pluripotentes Induzidas/citologia , Miócitos Cardíacos/citologia , Nanofibras/química , Poliésteres/química , Engenharia Tecidual/métodos , Alicerces Teciduais/química , Proteínas Wnt/metabolismo , beta Catenina/metabolismo , Animais , Células Cultivadas , Células-Tronco Pluripotentes Induzidas/metabolismo , Camundongos , Miócitos Cardíacos/metabolismo , Transdução de Sinais , Engenharia Tecidual/instrumentação , Proteínas Wnt/genética , beta Catenina/genética
8.
BMC Med ; 13: 217, 2015 Sep 09.
Artigo em Inglês | MEDLINE | ID: mdl-26354718

RESUMO

BACKGROUND: PARP inhibitors have shown promising clinical results in cancer patients carrying BRCA1/2 mutations. Their clinical efficacy could logically be influenced by PARP1 protein levels in patient tumors. METHODS: We screened three cohorts of patients with ovarian cancer, totaling 313 samples, and evaluated PARP1 protein expression by immunohistochemistry with further validation by western blotting. RESULTS: We observed that up to 60 % of tumors showed little PARP1 protein expression. In serous ovarian tumors, comparing intratumoral PARP1 expression between chemo-naïve and post-chemotherapy patients revealed a decrease in intratumoral PARP1 following chemotherapy in all three cohorts (immunohistochemistry: p < 0.001, n = 239; western blot: p = 0.012, n = 74). The findings were further confirmed in a selection of matched samples from the same patients before and after chemotherapy. CONCLUSION: Our data suggest that patients should be screened for PARP1 expression prior to therapy with PARP inhibitors. Further, the observed reduction of intratumoral PARP1 post-chemotherapy suggests that treating chemo-naïve patients with PARP inhibitors prior to the administration of chemotherapy, or concurrently, might increase the responsiveness to PARP1 inhibition. Thus, a change in the timing of PARP inhibitor administration may be warranted for future clinical trials.


Assuntos
Antineoplásicos/uso terapêutico , Neoplasias Ovarianas/tratamento farmacológico , Neoplasias Ovarianas/enzimologia , Inibidores de Poli(ADP-Ribose) Polimerases/uso terapêutico , Poli(ADP-Ribose) Polimerases/biossíntese , Idoso , Estudos de Coortes , Feminino , Humanos , Imuno-Histoquímica , Pessoa de Meia-Idade , Poli(ADP-Ribose) Polimerase-1 , Poli(ADP-Ribose) Polimerases/análise
9.
Bull World Health Organ ; 93(11): 775-84, 2015 Nov 01.
Artigo em Inglês | MEDLINE | ID: mdl-26549905

RESUMO

OBJECTIVE: To investigate the cost-effectiveness of a comprehensive programme for drug-resistant tuberculosis launched in four sites in China in 2011. METHODS: In 2011-2012, we reviewed the records of 172 patients with drug-resistant tuberculosis who enrolled in the comprehensive programme and we collected relevant administrative data from hospitals and China's public health agency. For comparison, we examined a cohort of 81 patients who were treated for drug-resistant tuberculosis in 2006-2009. We performed a cost-effectiveness analysis, from a societal perspective, that included probabilistic uncertainty. We measured early treatment outcomes based on three-month culture results and modelled longer-term outcomes to facilitate estimation of the comprehensive programme's cost per disability-adjusted life-year (DALY) averted. FINDINGS: The comprehensive programme cost 8837 United States dollars (US$) per patient treated. Low enrolment rates meant that some fixed costs were higher, per patient, than expected. Although the comprehensive programme appeared 30 times more costly than the previous one, it resulted in greater health benefits. The comprehensive programme, which cost US$ 639 (95% credible interval: 112 to 1322) per DALY averted, satisfied the World Health Organization's criterion for a very cost-effective intervention. CONCLUSION: The comprehensive programme, which included rapid screening, standardized care and financial protection, improved individual outcomes for MDR tuberculosis in a cost-effective manner. To support post-2015 global heath targets, the comprehensive programme should be expanded to non-residents and other areas of China.


Assuntos
Promoção da Saúde/economia , Promoção da Saúde/estatística & dados numéricos , Tuberculose Resistente a Múltiplos Medicamentos/economia , Adolescente , Adulto , China/epidemiologia , Estudos de Coortes , Análise Custo-Benefício , Feminino , Promoção da Saúde/métodos , Humanos , Masculino , Prontuários Médicos , Pessoa de Meia-Idade , Mycobacterium tuberculosis/efeitos dos fármacos , Mycobacterium tuberculosis/isolamento & purificação , Anos de Vida Ajustados por Qualidade de Vida , Escarro/microbiologia , Tuberculose Resistente a Múltiplos Medicamentos/diagnóstico , Tuberculose Resistente a Múltiplos Medicamentos/tratamento farmacológico , Tuberculose Resistente a Múltiplos Medicamentos/epidemiologia , Adulto Jovem
10.
Sci Rep ; 14(1): 626, 2024 Jan 05.
Artigo em Inglês | MEDLINE | ID: mdl-38182715

RESUMO

Shenfu Dongsheng coal field is a cross-century energy base which is developed and constructed in China. In recent years, some mines have successively entered to the coal seam of the second layer. Due to the reasons of early mining, many coal pillars are left in the coal seam of the first layer, resulting in the phenomenon of strong ore pressure in the mining range before and after the coal pillar in the lower coal seam and even causing the buckling accident. In order to solve such safety problems, this paper takes the 22,307 working face in Bulianta coal mine as the research object, adopts physical similarity simulation experiment and theoretical analysis to systematically study the overlying rock characteristics and abnormal ore pressure manifestation mechanism of shallow and close coal seam in different working stages. The results show that the roof overburden of the key layer in the lower group bends and sinks when the coal pillar is mined, resulting in the activation and instability of the "masonry beam" structure formed by the roof of the upper coal seam. When the coal pillar is discharged, the residual concentrated coal pillar and the room type coal pillar are unstable under the action of high supporting stress, resulting in shear failure of the inter-layer rock in the upper part of 22,307 working face, causing the strong dynamic pressure of the working face to appear and then leading to the buckling accident. The working resistance of the support in each stage is obtained by establishing the structure diagram of the overlying rock under each stage and the corresponding mechanical structure model. Finally, the working resistance required by the support in the mining stage under the goaf is 16,692.6 kN, the working resistance required by the support in the coal pillar stage is 19,692.6 kN, the working resistance required by the support in the mining stage under the concentrated coal pillar is 13,150.6 kN, and the working resistance required by the support in the coal pillar stage is 19,215.6 kN.

11.
Emerg Microbes Infect ; 13(1): 2361814, 2024 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-38828746

RESUMO

Echovirus 11 (E11) has gained attention owing to its association with severe neonatal infections. From 2018 to 2023, a surge in severe neonatal cases and fatalities linked to a novel variant of genotype D5 was documented in China, France, and Italy. However, the prevention and control of E11 variants have been hampered by limited background data on the virus circulation and genetic variance. Therefore, the present study investigated the circulating dynamics of E11 and the genetic variation and molecular evolution of genotype D5 through the collection of strains from the national acute flaccid paralysis (AFP) and hand, foot, and mouth disease (HFMD) surveillance system in China during 2000-2022 and genetic sequences published in the GenBank database. The results of this study revealed a prevalent dynamic of E11 circulation, with D5 being the predominant genotype worldwide. Further phylogenetic analysis of genotype D5 indicated that it could be subdivided into three important geographic clusters (D5-CHN1: 2014-2019, D5-CHN2: 2016-2022, and D5-EUR: 2022-2023). Additionally, variant-specific (144) amino acid mutation sites and positive-selection pressure sites (132, 262) were identified in the VP1 region. Cluster-specific recombination patterns were also identified, with CVB5, E6, and CVB4 as the major recombinant viruses. These findings provide a preliminary landscape of E11 circulation worldwide and basic scientific data for further study of the pathogenicity of E11 variants.


Assuntos
Enterovirus Humano B , Evolução Molecular , Variação Genética , Genótipo , Filogenia , China/epidemiologia , Humanos , Enterovirus Humano B/genética , Enterovirus Humano B/classificação , Enterovirus Humano B/isolamento & purificação , Recém-Nascido , Infecções por Echovirus/virologia , Infecções por Echovirus/epidemiologia , Doença de Mão, Pé e Boca/virologia , Doença de Mão, Pé e Boca/epidemiologia , Lactente
12.
BMC Cell Biol ; 14: 5, 2013 Jan 25.
Artigo em Inglês | MEDLINE | ID: mdl-23350814

RESUMO

BACKGROUND: The interactions between stem cells and extracellular matrix (ECM) mediated by integrins play important roles in the processes that determine stem cell fate. However, the role of ECM/integrin interaction in the formation of embryoid bodies (EBs) during cardiogenesis from murine induced pluripotent stem cells (miPSCs) remains unclear. RESULTS: In the present study, collagen type I and ß(1) integrin were expressed and upregulated synergistically during the formation of miPSC-derived EBs, with a peak expression at day 3 of differentiation. The blockage of collagen/ß(1) integrin interaction by ß(1) integrin blocking antibody resulted in the production of defective EBs that were characterized by decreased size and the absence of a shell-like layer composed of primitive endoderm cells. The quantification of spontaneous beating activity, cardiac-specific gene expression and cardiac troponin T (cTnT) immunostaining showed that the cardiac differentiation of these defective miPSC-derived EBs was lower than that of control EBs. CONCLUSIONS: These findings indicate that collagen/ß(1) integrin interaction is required for the growth and cardiac differentiation of miPSC-derived EBs and will be helpful in future engineering of the matrix microenvironment within EBs to efficiently direct the cardiac fate of pluripotent stem cells to promote cardiovascular regeneration.


Assuntos
Colágeno Tipo I/metabolismo , Corpos Embrioides/citologia , Células-Tronco Pluripotentes Induzidas/metabolismo , Integrina beta1/metabolismo , Animais , Anticorpos/imunologia , Diferenciação Celular , Células Cultivadas , Células-Tronco Embrionárias/citologia , Células-Tronco Embrionárias/metabolismo , Imuno-Histoquímica , Células-Tronco Pluripotentes Induzidas/citologia , Integrina beta1/imunologia , Camundongos , Microscopia Eletrônica de Varredura , Miocárdio/citologia , Ligação Proteica , Troponina T/metabolismo
13.
Mediators Inflamm ; 2012: 805149, 2012.
Artigo em Inglês | MEDLINE | ID: mdl-22778498

RESUMO

Cardiac hypertrophy is an independent predictor of cardiovascular morbidity and mortality. In recent years, evidences suggest that high-mobility group box 1 (HMGB1) protein, an inflammatory cytokine, participates in cardiac remodeling; however, the involvement of HMGB1 in the pathogenesis of cardiac hypertrophy remains unknown. The aim of this study was to investigate whether HMGB1 is sufficient to induce cardiomyocyte hypertrophy and to identify the possible mechanisms underlying the hypertrophic response. Cardiomyocytes isolated from 1-day-old Sprague-Dawley rats were treated with recombinant HMGB1, at concentrations ranging from 50 ng/mL to 200 ng/mL. After 24 hours, cardiomyocytes were processed for the evaluation of atrial natriuretic peptide (ANP) and calcineurin A expression. Western blot and real-time RT-PCR was used to detect protein and mRNA expression levels, respectively. The activity of calcineurin was also evaluated using a biochemical enzyme assay. HMGB1 induced cardiomyocyte hypertrophy, characterized by enhanced expression of ANP, and increased protein synthesis. Meanwhile, increased calcineurin activity and calcineurin A protein expression were observed in cardiomyocytes preconditioned with HMGB1. Furthermore, cyclosporin A pretreatment partially inhibited the HMGB1-induced cardiomyocyte hypertrophy. Our findings suggest that HMGB1 leads to cardiac hypertrophy, at least in part through activating calcineurin.


Assuntos
Calcineurina/metabolismo , Cardiomegalia/metabolismo , Proteína HMGB1/farmacologia , Miócitos Cardíacos/efeitos dos fármacos , Miócitos Cardíacos/metabolismo , Animais , Animais Recém-Nascidos , Fator Natriurético Atrial/metabolismo , Western Blotting , Calcineurina/genética , Células Cultivadas , Ratos , Ratos Sprague-Dawley , Reação em Cadeia da Polimerase em Tempo Real
14.
J Hazard Mater ; 433: 128781, 2022 07 05.
Artigo em Inglês | MEDLINE | ID: mdl-35405587

RESUMO

In this study, chitosan-based silicon nanoparticles (Chsi-NPs) are prepared that primarily consists of C (57.9%), O (31.3%), N (5.6%), and Si (3.5%) and are 10-180 nm in size. We then explore the effect on the foliage applied on rice planted on soil contaminated with 104 mg·kg-1 arsenic (As); low (3 mg·L-1)and high (15 mg·L-1) doses of the foliar Chsi-NPs are administered during the rice grain filling stage. The results showed that the higher dose foliar Chsi-NPs treatment reduced the As concentration in the grain by 61.2% but increased As concentration in the leaves by 47.1% compared to the control treatment. The foliar spraying of the Chsi-NPs inhibited As transport to the grain by facilitating the attachment of As to the cell wall, with higher doses of the foliar Chsi-NPs treatment increased by 8.7%. The foliar spraying of Chsi-NPs increased the malondialdehyde levels by 18.4%, the catalase activity by 49.0%, and the glutathione activity by 99.0%. These results indicated that the foliar Chsi-NPs application was effective for alleviating As toxicity and accumulation in rice. This study provides a novel method for effectively alleviating As accumulation in rice.


Assuntos
Arsênio , Quitosana , Nanopartículas , Oryza , Poluentes do Solo , Arsênio/análise , Arsênio/toxicidade , Cádmio/análise , Quitosana/farmacologia , Grão Comestível/química , Silício/farmacologia , Solo , Poluentes do Solo/análise , Poluentes do Solo/toxicidade
15.
J Cell Biochem ; 112(12): 3555-62, 2011 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-21780160

RESUMO

The cardiomyocyte (CM) differentiation of embryonic stem cells (ESCs) is routinely cultured as two-dimensional (2D) monolayer, which doesn't mimic in vivo physiological environment and may lead to low differentiated level of ESCs. Here, we develop a novel strategy that enhances CM differentiation of ESCs in collagen matrix three-dimensional (3D) culture combined with indirect cardiac fibroblasts co-culture. ESCs were cultured in hanging drops to form embryoid bodies (EBs) and then applied on collagen matrix. The EBs were indirectly co-cultured with cardiac fibroblasts by the hanging cell culture inserts (PET 1 µm). The molecular expressions and ultrastructural characteristics of ESC-derived CMs (ESCMs) were analyzed by real time RT-PCR, immunocytochemistry, and Transmission Electron Microscopy (TEM). We found that the percentage of beating EBs with cardiac fibroblasts co-culture was significantly higher than that without co-culture after differentiation period of 8 days. Type I collagen used as 3D substrates enhanced the late-stage CM differentiation of ESCs and had effect on ultrastructural mature of ESCMs in late-stage development. The combined effects of 3D and co-culture that mimic in vivo physiological environment further improved the efficiency of CM differentiation from ESCs, resulting in fiber-like structures of cardiac cells with organized sarcomeric structure in ESCMs. This novel 3D co-culture system emphasizes the fact that the ESC differentiation is actively responding to cues from their environment and those cues can drive phenotypic control, which provides a useful in vitro model to investigate CM differentiation of stem cells.


Assuntos
Diferenciação Celular , Células-Tronco Embrionárias/citologia , Miocárdio/citologia , Animais , Sequência de Bases , Técnicas de Cocultura , Primers do DNA , Células-Tronco Embrionárias/ultraestrutura , Imuno-Histoquímica , Camundongos , Microscopia Eletrônica de Transmissão , Reação em Cadeia da Polimerase em Tempo Real , Reação em Cadeia da Polimerase Via Transcriptase Reversa
16.
Biomarkers ; 16(8): 657-62, 2011 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-21988056

RESUMO

CONTEXT: Omentin-1, an adipokine secreted from visceral adipose tissue, has been reported to be associated with coronary artery disease (CAD) and metabolic disorders. OBJECTIVE: To clarify the relationship between serum omentin-1 levels and the presence and severity of CAD in patients with metabolic syndrome (MetS). METHODS: We measured serum omentin-1 levels in 175 consecutive patients with MetS and in 46 controls. RESULTS: Serum omentin-1 levels are inversely associated with the presence and angiographic severity of CAD in MetS patients. CONCLUSIONS: Serum omentin-1 might be a potential biomarker to predict the development and progression of CAD in MetS patients.


Assuntos
Doença da Artéria Coronariana/sangue , Citocinas/metabolismo , Lectinas/metabolismo , Síndrome Metabólica/sangue , Estudos de Casos e Controles , Doença da Artéria Coronariana/complicações , Proteínas Ligadas por GPI/metabolismo , Humanos , Síndrome Metabólica/complicações
17.
Bioessays ; 31(2): 246-52, 2009 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-19204979

RESUMO

Biological pacemakers can be achieved by various gene-based and cell-based approaches. Embryonic stem cells (ESCs)-derived pacemaker cells might be the most promising way to form biological pacemakers, but there are challenges as to how to control the differentiation of ESCs and to overcome the neoplasia, proarrhythmia, or immunogenicity resulting from the use of ESCs. As a potential approach to solve these difficult problems, tissue-engineering techniques may provide a precise control on the different cell components of multicellular aggregates and the forming of a construct with-defined architectures and functional properties. The combined interactions between ESC-derived pacemaker cells, supporting cells, and matrices may completely reproduce pacemaker properties and result in a steady functional unit to induce rhythmic electrical and contractile activities. As ESCs have a high capability for self-renewal, proliferation, and potential differentiation, we hypothesize that ESCs can be used as a source of pacemaker cells for tissue-engineering applications and the ambitious goal of biological cardiac pacemakers may ultimately be achieved with ESCs via tissue-engineering technology.


Assuntos
Relógios Biológicos , Células-Tronco Embrionárias/metabolismo , Engenharia Tecidual , Animais , Humanos
18.
Zhongguo Yi Xue Ke Xue Yuan Xue Bao ; 33(1): 80-2, 2011 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-21375944

RESUMO

OBJECTIVE: To evaluate the clinical value of fine needle aspiration cytology (FNAC) for breast cancer surgery. METHODS: FNAC was performed in 530 patients highly suspected of breast cancer from January 2004 to January 2009 in Peking Union Medical College Hospital. The FNAC-positive cases received radical operation directly, while the negative cases received open biopsy. RESULTS: Of all 530 cases, 325 cases were FNAC-positive, and the diseases were histopathologically confirmed to be malignant. Among 205 FNAC-negative cases, 137 cases were histopathologically confirmed to be malignant and 68 benign. CONCLUSION: FNAC is useful in the deciding surgical modes for women with potentially malignant diseases.


Assuntos
Biópsia por Agulha Fina , Neoplasias da Mama/cirurgia , Adulto , Idoso , Neoplasias da Mama/patologia , Feminino , Humanos , Pessoa de Meia-Idade
19.
Zhongguo Yi Xue Ke Xue Yuan Xue Bao ; 33(2): 136-41, 2011 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-21529439

RESUMO

OBJECTIVE: To evaluate the impact of lesion size on the detection rate of non-palpable breast malignant lesions and determine whether lesion size should prompt biopsy of non-palpable breast lesions. METHODS: The study included 816 ultrasonographically detected non-palpable breast lesions. We divided the lesions into five groups based on their largest diameters: ≤0.5cm, 0.6-1.0cm, 1.1-1.5cm, 1.6-2.0 cm, and >2.0 cm. The detection rate of malignancies of different sizes were compared among these lesions, Breast Imaging Reporting and Data System (BI-RADS) category 2-3 lesions, and BI-RADS grades 4-5 lesions. The feasibility of using lesion size as biopsy indicator for BI-RADS category 2-3 non-palpable breast lesion was analyzed using ROC curve. RESULTS: Of these 816 lesions, 100 (12.3%) were found to be malignant lesions. The detection rate of malignancy significantly increased along with the increase of lesion size (P<0.05). When the BI-RADS category was not considered, the frequency of malignancy in the >2.0 cm group was significantly higher than in other groups (P<0.05) The frequencies of malignancy in the 0.6-1.0 cm group, 1.1-1.5 cm group, and 1.6-2.0 cm group were higher than that in ≤0.5 cm group, but the difference was not significant (P>0.05) For BI RADS category 4 and 5 lesions, the frequency of malignancy in >2.0 cm group was higher than in other groups, but significant difference was only seen between >2.0 cm group and ≤0.5 cm group (P<0.05). CONCLUSIONS: Lesion size may influence the detection rate of malignancy of non palpable breast lesions, and can be used as biopsy indicator of non palpable breast lesions in BI-RADS 2,3 category When we use 1.25cm as threshold,the sensitivity and specificity may be satisfying.


Assuntos
Neoplasias da Mama/diagnóstico por imagem , Mama/patologia , Neoplasias da Mama/patologia , Feminino , Humanos , Sensibilidade e Especificidade , Ultrassonografia Mamária
20.
Clin Exp Pharmacol Physiol ; 37(1): 40-5, 2010 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-19515066

RESUMO

1. The scaffolding protein Homer 1a is constitutively expressed in the myocardium, although its function in cardiomyocytes remains poorly understood. The aim of the present study was to investigate Homer 1a expression in hypertrophic cardiac cells and its role in angiotensin (Ang) II-induced cardiac hypertrophy. 2. After serum starvation for 24 h, cells were treated with 1 micromol/L simvastatin, 100 nmol/L angiotensin (Ang) II or their combination added to Dulbecco's modified Eagle's medium containing 0.5% serum. For combination treatment with AngII plus simvastatin, cells were exposed to simvastatin 12 h before the addition of AngII to the medium and cells were then incubated in the presence of both drugs for a further 24 h. Western blotting was used to determine Homer 1a protein expression. Hypertrophy was evaluated by determining the protein content per cell. 3. Homer 1a protein levels were upregulated following AngII-induced hypertrophy in H9C2 cells and neonatal rat cardiomyocytes, and these increases were augmented by simvastatin pretreatment. Concomitantly, simvastatin pretreatment inhibited extracellular signal-regulated kinase (ERK) 1/2 phosphorylation and AngII-induced hypertrophy. 4. The inhibitory effects of simvastatin against AngII-induced hypertrophy were attenuated by Homer 1a silencing, suggesting that simvastatin suppresses cardiac hypertrophy in a Homer 1a-dependent manner. Furthermore, AngII-induced hypertrophy and ERK1/2 phosphorylation in neonatal rat cardiomyocytes were significantly inhibited following the overexpression of Homer 1a using an adenovirus. 5. These results suggest a possible role for Homer 1a in inhibiting cardiac hypertrophy perhaps in part through inhibition of ERK1/2 activation.


Assuntos
Angiotensina II/antagonistas & inibidores , Anticolesterolemiantes/farmacologia , Cardiomegalia/fisiopatologia , Proteínas de Transporte/fisiologia , Miócitos Cardíacos/metabolismo , Sinvastatina/farmacologia , Angiotensina II/administração & dosagem , Angiotensina II/farmacologia , Animais , Animais Recém-Nascidos , Anticolesterolemiantes/administração & dosagem , Cardiomegalia/induzido quimicamente , Cardiomegalia/tratamento farmacológico , Cardiomegalia/metabolismo , Linhagem Celular , Interações Medicamentosas , Quimioterapia Combinada , MAP Quinases Reguladas por Sinal Extracelular/metabolismo , Proteínas de Arcabouço Homer , Fosforilação/efeitos dos fármacos , RNA Interferente Pequeno/administração & dosagem , RNA Interferente Pequeno/farmacologia , Ratos , Ratos Sprague-Dawley , Sinvastatina/administração & dosagem , Transfecção/métodos , Regulação para Cima
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA